End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8692 USD | -6.54% | -7.60% | -57.39% |
Financials (USD)
Sales 2024 * | 413M | Sales 2025 * | 483M | Capitalization | 64.59M |
---|---|---|---|---|---|
Net income 2024 * | -50M | Net income 2025 * | -36M | EV / Sales 2024 * | 0.16 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.13 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.69% |
Latest transcript on The Oncology Institute, Inc.
1 day | -6.54% | ||
1 week | -7.60% | ||
Current month | -18.00% | ||
1 month | -32.09% | ||
3 months | -55.88% | ||
6 months | -65.91% | ||
Current year | -57.39% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Virnich
CEO | Chief Executive Officer | 46 | 18-12-31 |
Mihir Shah
DFI | Director of Finance/CFO | 45 | 22-04-03 |
Jeremy Castle
COO | Chief Operating Officer | 41 | 23-09-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Barasch
CHM | Chairman | 70 | 21-11-11 |
Mark Pacala
BRD | Director/Board Member | 68 | 22-09-20 |
Bradford Hively
BRD | Director/Board Member | 45 | 18-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 0.8692 | -6.54% | 224,398 |
24-05-10 | 0.93 | -2.22% | 101,095 |
24-05-09 | 0.9511 | +3.55% | 101,115 |
24-05-08 | 0.9185 | +3.96% | 236,960 |
24-05-07 | 0.8835 | -6.08% | 233,276 |
End-of-day quote Nasdaq, May 12, 2024
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-57.39% | 69.11M | |
+17.18% | 85.55B | |
-28.48% | 70.07B | |
+6.76% | 28.95B | |
-7.44% | 17.51B | |
+2.14% | 17.39B | |
+2.10% | 15.38B | |
+7.02% | 13.4B | |
+64.96% | 12.93B | |
+6.64% | 12.77B |
- Stock Market
- Equities
- TOI Stock